Publications and Presentations Database
Conference Presentation
Roberts, J. S., Green, R. C., Relkin, N., Whitehouse, P., Brown, T., Barber, M., et al.
(2002).
Genetic susceptibility testing for adult children of patients with Alzheimer’s disease: Participants’ self-reports on the impact of risk assessment.
LaRusse, S., Katzen, H, Roberts, J. S., Barber, M., Brown, T., Whitehouse, P., et al.
(2002).
Genetic test results alter perception of risk of Alzheimer's disease: Preliminary results of the REVEAL Study.
Roberts, J. S., Green, R. C., Nelkin, N., Whitehouse, P., Brown, T., Barber, M., et al.
(2003).
How do participants rate the impact of genetic susceptibility testing for Alzheimer’s disease?.
Roberts, J. S., Lock, M., Prest, J., Barber, M., Whitehouse, P., LaRusse, S., et al.
(2004).
How does genetic testing affect anxiety about developing Alzheimer’s disease? .
Green, R. C., Roberts, J. S., Brown, T. C., Whitehouse, P. J., Barber, M., Relkin, N. R., et al.
(2002).
How many adult children of patients with Alzheimer’s disease will choose genetic susceptibility testing with APOE genotyping?.
Brown, T., Roberts, J. S., LaRusse, S., Barber, M., Relkin, N., Whitehouse, P., et al.
(2002).
Impact of genetic risk assessment for Alzheimer’s disease.
LaRusse, S., Katzen, H., Brown, T., Barber, M., Whitehouse, P. J., Green, R. C., et al.
(2002).
Participant recall of their own apolipoprotein E (APOE) genotype and risk estimate after six weeks: Results from the REVEAL Study.
] 